Aandelen in “Diensten aan de gezondheidssector”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Diensten aan de gezondheidssector”

1/07 · Equasens: General meeting - Results of the votes · Persbericht

1/07 · Equasens: General meeting - Results of the votes · Persbericht

30/06 · Equasens: acquisition of DIS and RESURGENCES BUSINESSES · Persbericht

13/06 · Cegedim : Implementation of the plan to transfer the listing of the Group's shares on Euronext Growth · Persbericht

11/06 · Cegedim: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS · Persbericht

6/06 · Equasens: availability of AGM preparatory materials · Persbericht

23/05 · DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS · Persbericht

15/05 · Quest Diagnostics Declares Quarterly Cash Dividend · Persbericht

13/05 · Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds · Persbericht

12/05 · Equasens: Q1 revenue at 31 March 2025 · Persbericht

9/05 · Cegedim: plan to transfer its shares to Euronext Growth Paris. · Persbericht

8/05 · Labcorp to Webcast Its Annual Meeting of Shareholders May 15 · Persbericht

7/05 · Promethean partners with Google on powerful plug-in ChromeOS device · Persbericht

1/05 · Promethean's ActivPanel 10 Premium wins prestigious Red Dot Design Award 2025 · Persbericht

30/04 · Equasens: EXCLUSIVE NEGOTIATIONS INITIATED WITH A FRENCH SOFTWARE EDITOR · Persbericht

29/04 · Labcorp Announces 2025 First Quarter Results · Persbericht

24/04 · Cegedim: Like-for-like revenues grew 4.5% in the first quarter · Persbericht

23/04 · Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions · Persbericht

22/04 · Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 · Persbericht

18/04 · DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS · Persbericht

10/04 · Labcorp Declares Quarterly Dividend · Persbericht

Mijn selecties